No photo of Michael (Mike) Powers

View Scopus Profile

Michael (Mike) Powers

Professor

  • 955 Citations
  • 15 h-Index
1990 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michael (Mike) Powers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Fibroblast Growth Factor 2 Medicine & Life Sciences
Retinal Neovascularization Medicine & Life Sciences
Hyperoxia Medicine & Life Sciences
Retina Medicine & Life Sciences
Mast Cells Medicine & Life Sciences
Oxygen Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1991 2013

GROWTH FACTORS IN OXYGEN INJURED NEONATAL EYES

Powers, M. (.

National Institutes of Health

4/1/98 → 8/31/13

Project: Research project

Retinopathy of Prematurity
Retinal Neovascularization
Apoptosis
Oxygen
Intercellular Signaling Peptides and Proteins

GROWTH FACTORS IN NEONATAL HYPEROXIC EYE AND LUNG INJURY

Powers, M. (. & Tomarev, S.

National Institutes of Health

8/1/91 → 7/31/96

Project: Research project

Eye Injuries
Lung Injury
Intercellular Signaling Peptides and Proteins
Retinopathy of Prematurity
Lung

Research Output 1990 2018

  • 955 Citations
  • 15 h-Index
  • 27 Article
  • 1 Letter
6 Citations (Scopus)

Changes in lung clearance index in preschool-aged patients with cystic fibrosis treated with ivacaftor (GOAL): A clinical trial

Ratjen, F., Klingel, M., Black, P., Powers, M. M., Grasemann, H., Solomon, M., Sagel, S. D., Donaldson, S. H., Rowe, S. M. & Rosenfeld, M., Aug 15 2018, In : American Journal of Respiratory and Critical Care Medicine. 198, 4, p. 526-528 3 p.

Research output: Contribution to journal › Letter

Cystic Fibrosis
Clinical Trials
Lung
ivacaftor
28 Citations (Scopus)

Effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first year of life

Baby Observational and Nutrition Study (BONUS) Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network, Jun 1 2017, In : JAMA Pediatrics. 171, 6, p. 546-554 9 p.

Research output: Contribution to journal › Article

Cystic Fibrosis
Newborn Infant
Weights and Measures
Observational Studies
Birth Weight
10 Citations (Scopus)

Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy

Davies, M. H., Stempel, A. J., Hubert, K. E. & Powers, M. M., 2010, In : Developmental Dynamics. 239, 6, p. 1695-1707 13 p.

Research output: Contribution to journal › Article

Hyperoxia
Retinal Neovascularization
Blood Vessels
Oxygen
EphB4 Receptor
13 Citations (Scopus)

Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells

Davies, M. H., Zamora, D. O., Smith, J. R. & Powers, M. M., May 2009, In : Microvascular Research. 77, 3, p. 382-386 5 p.

Research output: Contribution to journal › Article

Ephrin-B2
Retinal Neovascularization
Endothelial cells
Caspase 3
Endothelial Cells
10 Citations (Scopus)

TRAIL-deficient mice exhibit delayed regression of retinal neovascularization

Hubert, K. E., Davies, M. H., Stempel, A. J., Griffith, T. S. & Powers, M. M., 2009, In : American Journal of Pathology. 175, 6, p. 2697-2708 12 p.

Research output: Contribution to journal › Article

Retinal Neovascularization
Oxygen
Apoptosis
Retina
TNF-Related Apoptosis-Inducing Ligand Receptors